- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000+ real adjudications. Browse free — subscribe to search by company, clause and case reference.
1,914 cases · Unlock search, clause & company filters ↓
PMCPA found Bayer failed to post Phase I Xofigo trial results within the required 12 months after first licensing/commercial availability…
Pulse Online rolling banner for Nicorette included the generic name but the first banner lacked a clear, prominent single-click link…
Anonymous complaint about Sanofi reps’ call-rate expectations. Panel found no proof of over-calling, but a manager email pushing higher contact…
Biogen UK was found in breach for late disclosure of three Phase I/II Tecfidera trials. Results should have been public…
Celgene’s Otezla “meetings in a box” slide decks were certified as if for rep use only, but were also used…
ABBH nurse audit programme materials linked offering an osteoporosis audit service to agreement to prescribe Actonel. Breaches of Clauses 18.1…
Roche’s BMJ MabThera ad showing a high-jump athlete and “Recommended by NICE” was challenged as misleading and raising false hope.…
A GP complained an MSD meeting invitation looked unprofessional and unclear. The Panel found the company identity and meeting arrangements…
Ferriprox banner ad linked UK clinicians to a page reusing “Life is Getting Longer…”, previously ruled a hanging comparison. Panel…
A PCT complained an AstraZeneca rep missed a rebooked appointment and didn’t explain. Panel criticised use of a personal PDA…
Schering placed a LARC information feature in an M&S magazine. Complaint alleged missing progestogen safety warnings. Panel found the piece…
Lilly sponsored a freelance journalist to attend ESSM where a Cialis symposium (incl. unlicensed once-daily regimen) was compulsory. Two lay-press…
A paid-for journal ad promoting awareness of GSK’s TORCH COPD study was deemed an indirect product advertisement for Serevent/Flixotide/Seretide and…
PMCPA case AUTH/3002/12/17 (Director v Octapharma) concerning clinical trial disclosure for Nuwiq. Outcome: No breach; matter found to be outwith…
PMCPA case AUTH/2788/8/15: complaint about paying for a Lyrica switch. Outcome: No breach; matter considered outwith the scope of the…
PMCPA recorded the complaint as outwith the scope of the ABPI Code (2012). No breach was found and no case…
GSK’s corporate Twitter shared Zejula trial/regulatory updates in a Q2 results thread. PMCPA said the tweet was accessible to the…
A GP complained about a rep’s non-headed letter seeking an appointment but making efficacy/price claims. PMCPA ruled it was promotional,…
A BMJ-hosted promotional ‘tile’ for Viridal showed the brand name without the non-proprietary name and lacked certification. UCB said an…
Galderma’s GP letter promoting Silkis as an alternative to Dovonex used broad claims on steroid comparability, cosmetic acceptability and “cost…
Members can instantly filter all 2,000+ cases by any of the 154 PMCPA clauses and 291 pharmaceutical companies — plus get video walkthroughs, expert podcasts and CPD certificates for every case.
One real case. One key lesson. Every week — free.